Patent 7799533 was granted and assigned to Takeda Pharmaceutical Company on September, 2010 by the United States Patent and Trademark Office.
This invention relates to a novel polypeptide involving in the modulation of central nervous system function, circulatory function, immune function, gastrointestinal function, metabolic function, reproductive function, etc., it can be used as a drug for treating or preventing a variety of diseases, e.g. HIV infection or AIDS (acquired immune deficiency syndrome) or the like.